2018-2025 Lung Cancer Diagnostic Tests Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

January 2018 | 129 pages | ID: 2C38AF8F5D7EN
QYResearch

Abstracts

Summary

This report studies the Lung Cancer Diagnostic Tests market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Lung Cancer Diagnostic Tests market by product type and application/end industries.

The global Lung Cancer Diagnostic Tests market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lung Cancer Diagnostic Tests.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Lung Cancer Diagnostic Tests in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Advpharma Inc
• AIT Austrian Institute of Technology GmbH
• Courtagen Life Sciences Inc
• DiagnoCure Inc. (Inactive)
• BioMark Diagnostics Inc.
• BioMarker Strategies LLC
• Emory University
• Epigenomics AG
• GlycoZym
• HalioDx SAS
• Louisville Bioscience, Inc.
• Mayo Clinic US

On the basis of product, the market is primarily split into

• Immunoassays
• Flow Cytometry
• Rapid Tests
• Molecular Assays
• Tissue Arrays
• Circulating Tumor Cells
• Pharmacodiagnostics
• Biomarkers
• Other Diagnostics Methods

On the basis on the end users/application, this report covers

• Precision Medicine
• Personalized Medicine
• Cancer Monitoring

Contents

2018-2025 LUNG CANCER DIAGNOSTIC TESTS REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 LUNG CANCER DIAGNOSTIC TESTS MARKET OVERVIEW

2.1 Lung Cancer Diagnostic Tests Product Overview
2.2 Lung Cancer Diagnostic Tests Market Segment by Type
  2.2.1 Immunoassays
  2.2.2 Flow Cytometry
  2.2.3 Rapid Tests
  2.2.4 Molecular Assays
  2.2.5 Tissue Arrays
  2.2.6 Circulating Tumor Cells
  2.2.7 Pharmacodiagnostics
  2.2.8 Biomarkers
  2.2.9 Other Diagnostics Methods
2.3 Global Lung Cancer Diagnostic Tests Product Segment by Type
  2.3.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Lung Cancer Diagnostic Tests Price (USD/Pcs) by Type (2013-2018)
2.4 United States Lung Cancer Diagnostic Tests Product Segment by Type
  2.4.1 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Lung Cancer Diagnostic Tests Price (USD/Pcs) by Type (2013-2018)

3 LUNG CANCER DIAGNOSTIC TESTS APPLICATION/END USERS

3.1 Lung Cancer Diagnostic Tests Segment by Application/End Users
  3.1.1 Precision Medicine
  3.1.2 Personalized Medicine
  3.1.3 Cancer Monitoring
3.2 Global Lung Cancer Diagnostic Tests Product Segment by Application
  3.2.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Lung Cancer Diagnostic Tests Product Segment by Application
  3.3.1 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 LUNG CANCER DIAGNOSTIC TESTS MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Lung Cancer Diagnostic Tests Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Lung Cancer Diagnostic Tests Sales and Revenue by Regions
  4.2.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Lung Cancer Diagnostic Tests Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Lung Cancer Diagnostic Tests Manufacturing Base Distribution, Sales Area, Product Types
5.5 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
  5.5.1 Lung Cancer Diagnostic Tests Market Concentration Rate
  5.5.2 Global Lung Cancer Diagnostic Tests Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Lung Cancer Diagnostic Tests Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Lung Cancer Diagnostic Tests Market Share (%) of Top 3 and Top 5 Players

7 LUNG CANCER DIAGNOSTIC TESTS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Advpharma Inc
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 AIT Austrian Institute of Technology GmbH
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Courtagen Life Sciences Inc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 DiagnoCure Inc. (Inactive)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 BioMark Diagnostics Inc.
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 BioMarker Strategies LLC
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Emory University
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Emory University Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Epigenomics AG
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 GlycoZym
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 HalioDx SAS
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Louisville Bioscience, Inc.
7.12 Mayo Clinic US

8 LUNG CANCER DIAGNOSTIC TESTS MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Lung Cancer Diagnostic Tests Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL LUNG CANCER DIAGNOSTIC TESTS MARKET FORECAST

10.1 Global Lung Cancer Diagnostic Tests Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Lung Cancer Diagnostic Tests Market Forecast
  10.2.1 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Lung Cancer Diagnostic Tests Forecast by Regions
  10.3.1 North America Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Lung Cancer Diagnostic Tests Forecast by Type
  10.4.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Lung Cancer Diagnostic Tests Forecast by Application
  10.5.1 Global Lung Cancer Diagnostic Tests Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Lung Cancer Diagnostic Tests Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Lung Cancer Diagnostic Tests Product Picture
Figure Global Lung Cancer Diagnostic Tests Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Immunoassays
Table Major Players of Immunoassays
Figure Global Immunoassays Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Flow Cytometry
Table Major Players of Flow Cytometry
Figure Global Flow Cytometry Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Rapid Tests
Table Major Players of Rapid Tests
Figure Global Rapid Tests Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Molecular Assays
Table Major Players of Molecular Assays
Figure Global Molecular Assays Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Tissue Arrays
Table Major Players of Tissue Arrays
Figure Global Tissue Arrays Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Circulating Tumor Cells
Table Major Players of Circulating Tumor Cells
Figure Global Circulating Tumor Cells Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Pharmacodiagnostics
Table Major Players of Pharmacodiagnostics
Figure Global Pharmacodiagnostics Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Biomarkers
Table Major Players of Biomarkers
Figure Global Biomarkers Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Other Diagnostics Methods
Table Major Players of Other Diagnostics Methods
Figure Global Other Diagnostics Methods Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) by Type (2013-2018)
Table Global Lung Cancer Diagnostic Tests Sales Share (%) by Type (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Type (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Type in 2017
Table Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Type (2013-2018)
Table Global Lung Cancer Diagnostic Tests Revenue Share (%) by Type (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Lung Cancer Diagnostic Tests Revenue Market Share (%) by Type
Table Global Lung Cancer Diagnostic Tests Price (USD/Pcs) by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Share (%) by Type (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share (%) by Type (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share (%) by Type in 2017
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue Share (%) by Type (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Lung Cancer Diagnostic Tests Revenue Market Share (%) by Type
Table United States Lung Cancer Diagnostic Tests Price (USD/Pcs) by Type (2013-2018)
Figure Precision Medicine Examples
Figure Personalized Medicine Examples
Figure Cancer Monitoring Examples
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) by Application (2013-2018)
Table Global Lung Cancer Diagnostic Tests Sales Share (%) by Application (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Application (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Application in 2017
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) by Application (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Share (%) by Application (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share (%) by Application (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share (%) by Application in 2017
Table Global Lung Cancer Diagnostic Tests Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) by Regions (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Regions (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Lung Cancer Diagnostic Tests Sales Market Share (%) by Regions
Figure 2017 United States Lung Cancer Diagnostic Tests Sales Market Share (%) in Global Market
Table Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Regions (2013-2018)
Table Global Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions (2013-2018)
Figure Global Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Lung Cancer Diagnostic Tests Revenue Market Share (%) by Regions
Figure 2017 United States Lung Cancer Diagnostic Tests Revenue Market Share (%) in Global Market
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) of Key Players (2013-2018)
Table Global Lung Cancer Diagnostic Tests Sales Share (%) by Players (2013-2018)
Figure 2017 Global Lung Cancer Diagnostic Tests Sales Share (%) by Players
Figure 2018 Global Lung Cancer Diagnostic Tests Sales Share (%) by Players
Table Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Players (2013-2018)
Table Global Lung Cancer Diagnostic Tests Revenue Share (%) by Players (2013-2018)
Table 2017 Global Lung Cancer Diagnostic Tests Revenue Share (%) by Players
Table 2017 Global Lung Cancer Diagnostic Tests Revenue Share (%) by Players
Table Global Market Lung Cancer Diagnostic Tests Average Price (USD/Pcs) by Players (2013-2018)
Table Global Lung Cancer Diagnostic Tests Top Players Manufacturing Base Distribution and Sales Area
Table Global Lung Cancer Diagnostic Tests Top Players Product Category
Figure Global Lung Cancer Diagnostic Tests Market Share (%) of Top 3 Players
Figure Global Lung Cancer Diagnostic Tests Market Share (%) of Top 5 Players
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) by Players (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Lung Cancer Diagnostic Tests Sales Share (%) by Players
Figure 2018 United States Lung Cancer Diagnostic Tests Sales Share (%) by Players
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) by Players (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Lung Cancer Diagnostic Tests Revenue Share (%) by Players
Table 2017 United States Lung Cancer Diagnostic Tests Revenue Share (%) by Players
Table United States Market Lung Cancer Diagnostic Tests Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Market Share (%) of Top 3 Players
Figure United States Lung Cancer Diagnostic Tests Market Share (%) of Top 5 Players
Table Advpharma Inc Basic Information List
Table Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table AIT Austrian Institute of Technology GmbH Basic Information List
Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table Courtagen Life Sciences Inc Basic Information List
Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table DiagnoCure Inc. (Inactive) Basic Information List
Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table BioMark Diagnostics Inc. Basic Information List
Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table BioMarker Strategies LLC Basic Information List
Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table Emory University Basic Information List
Table Emory University Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table Epigenomics AG Basic Information List
Table Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table GlycoZym Basic Information List
Table GlycoZym Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table HalioDx SAS Basic Information List
Table HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales Global Market Share (%)(2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Revenue Global Market Share (%)(2013-2018)
Table Louisville Bioscience, Inc. Basic Information List
Table Mayo Clinic US Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lung Cancer Diagnostic Tests
Figure Lung Cancer Diagnostic Tests Industrial Chain Analysis
Table Major Buyers of Lung Cancer Diagnostic Tests
Table Distributors/Traders List
Figure Global Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Lung Cancer Diagnostic TestsLung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Lung Cancer Diagnostic Tests Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Lung Cancer Diagnostic Tests Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Lung Cancer Diagnostic Tests Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Lung Cancer Diagnostic Tests Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Lung Cancer Diagnostic Tests Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Lung Cancer Diagnostic Tests Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Lung Cancer Diagnostic Tests Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Lung Cancer Diagnostic Tests Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Lung Cancer Diagnostic Tests Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Lung Cancer Diagnostic Tests Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Lung Cancer Diagnostic Tests Sales Forecast by Application (2018-2025)
Table United States Lung Cancer Diagnostic Tests Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Forecast by Application (2018-2025)